Literature DB >> 27335359

Relapsing CD8+ encephalitis-looking for a solution.

Sharfaraz Salam1, Tatiana Mihalova2, Andrew Ustianowski3, David McKee2, Rehka Siripurapu4.   

Abstract

CD8+ encephalitis (CD8+E) is an emerging and incompletely understood HIV-associated neurological syndrome, typically presenting as a steroid-responsive subacute encephalopathy with prominent white matter changes in patients with apparently well-controlled HIV infection. Some cases can be associated with the phenomenon of 'viral escape' (disproportionate replication within the cerebrospinal fluid), but the most important pathophysiology of CD8+E is thought to involve an attack on HIV-infected CD4+ lymphocytes by autoreactive CD8+ cells. We report a case of CD8+E where the initial positive response to steroid treatment was followed by several relapses on withdrawal. This led to the use of mycophenolate mofetil (MMF) as a long-term steroid-sparing agent, which is the first time this approach has been reported in the literature. The patient has now been on treatment with MMF for 10 months and it has been possible to taper the steroids down to a minimal maintenance dose without further relapse. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27335359      PMCID: PMC4932356          DOI: 10.1136/bcr-2016-214961

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens.

Authors:  Natasha Press; Gil Kimel; Marianne Harris; Benita Yip; Kevin J P Craib; Julio S G Montaner
Journal:  HIV Clin Trials       Date:  2002 Jan-Feb

2.  Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines.

Authors:  R G Cohn; A Mirkovich; B Dunlap; P Burton; S H Chiu; E Eugui; J P Caulfield
Journal:  Transplantation       Date:  1999-08-15       Impact factor: 4.939

3.  CD8 transverse myelitis in a patient with HIV-1 infection.

Authors:  Antoine Moulignier; François-Xavier Lescure; Julien Savatovsky; Pauline Campa
Journal:  BMJ Case Rep       Date:  2014-02-06

4.  A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection.

Authors:  J J Coull; D Turner; T Melby; M R Betts; R Lanier; D M Margolis
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-15       Impact factor: 3.731

5.  Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment.

Authors:  Françoise Gray; François Xavier Lescure; Homa Adle-Biassette; Marc Polivka; Sébastien Gallien; Gilles Pialoux; Antoine Moulignier
Journal:  Brain Pathol       Date:  2013-03-18       Impact factor: 6.508

6.  Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.

Authors:  Mohammad M Hossain; Jason J Coull; George L Drusano; David M Margolis
Journal:  Antiviral Res       Date:  2002-07       Impact factor: 5.970

7.  The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

Authors:  David M Margolis; Stephen Kewn; Jason J Coull; Loyda Ylisastigui; Diana Turner; Holly Wise; Mohammed M Hossain; E Randall Lanier; Leslie M Shaw; David Back
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

Review 8.  Varicella zoster virus vasculopathy: clinical features and pathogenesis.

Authors:  Maria A Nagel
Journal:  J Neurovirol       Date:  2013-08-06       Impact factor: 2.643

9.  CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.

Authors:  François-Xavier Lescure; Antoine Moulignier; Julien Savatovsky; Corinne Amiel; Guislaine Carcelain; Jean-Michel Molina; Sébastien Gallien; Jérôme Pacanovski; Gilles Pialoux; Homa Adle-Biassette; Françoise Gray
Journal:  Clin Infect Dis       Date:  2013-03-20       Impact factor: 9.079

10.  Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects.

Authors:  Emily L Ho; Rollie Ronquillo; Hermann Altmeppen; Serena S Spudich; Richard W Price; Elizabeth Sinclair
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more
  2 in total

1.  CD8 encephalitis with CSF EBV viraemia and HIV drug resistance, a case series.

Authors:  C Kerr; H Adle-Biassette; P B Moloney; S Hutchinson; J B Cryan; S Clarke; F Mulcahy; E Devitt
Journal:  Brain Behav Immun Health       Date:  2020-10-23

2.  Reversible Small Vessel Vasculitis and Encephalitis in HIV Antiretroviral Resistance.

Authors:  Ryan T Muir; Suradech Suthiphosuwan; Aditya Bharatha; Amy Lin; David Munoz; Mario Ostrowski; Raphael Schneider
Journal:  J Neuropathol Exp Neurol       Date:  2021-01-01       Impact factor: 3.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.